Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. APIs - An Introduction

4. Global API Industry

5. Drivers & Challenges
     5.1 Drivers
            5.1.1 Rise in Geriatric Population
            5.1.2 Increasing Prevalence of Chronic Diseases
            5.1.3 Patent Expiry Opening Market for Generic APIs
            5.1.4 Asian Markets Offer Considerable Growth Potential
     5.2 Challenges
            5.2.1 Surging Prices Holding Back Branded Drug Market
            5.2.2 Increasingly Challenging Regulatory Environment
            5.2.3 Lengthy Product Approval Process
            5.2.4 Lack of Transparency in Supply Chain

6. Market Segmentation
     6.1 By Type of Manufacturing
            6.1.1 Captive Market
            6.1.2 Merchant Market
     6.2 By Type of Drug
            6.2.1 Generic Drug API
            6.2.2 Branded Drug API
     6.3 By Type of API
            6.3.1 Chemical/Small Molecule API
            6.3.2 Biotech API
     6.4 By Key Geographical Markets
            6.4.1 North America
            6.4.2 Asia-Pacific
            6.4.3 Europe
            6.4.4 Rest of the World
     6.5 By Therapeutic Segments
            6.5.1 Cardiovascular Diseases
            6.5.2 Diabetes
            6.5.3 Central Nervous System Disorders
            6.5.4 Oncology
            6.5.5 Others

7. Trends and Developments
     7.1 Nanocrystals of APIs to Improve Solubility
     7.2 Technological Advancements Aiding API Production

8. Competitive Landscape
     8.1 BASF SE
     8.2 Kyowa Hakko Kirin
     8.3 Teva Active Pharmaceuticals Ingredients
     8.4 Lonza
     8.5 Dr. Reddy’s Laboratories
     8.6 Aurobindo Pharma Limited
     8.7 Pfizer
     8.8 Divis Laboratories Limited
     8.9 Royal DSM
     8.10 Boehringer Ingelheim GmbH